Thus, understanding the dysregulation of the PACAP/VIP neuropeptide system in chronic neuroinflammation may pave the way for the development of novel therapeutic strategies for the treatment of MS and/or other relevant neurodegenerative diseases. Here, ADCYAP1 is linked to neurodegenerative disease.